| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Director | Chief Financial Officer | Chief Financial Officer
3 companies
Farr Kevin M is a Chief Financial Officer at MAT, with reported holdings spanning 3 companies. Recent filings cover 9 purchases and 4 sales. Those positions are worth an estimated $951K at current prices.
Our model assigns Farr Kevin M a middling insider score of 69/100, based on 3 past trades. Over a 12-month horizon, 100.0% of those trades were profitable, with an average 12-month return of +29.5%.
Farr Kevin M's largest disclosed position is in PII as Director, worth about $766K. The recent filings there lean toward selling, a net 11,784 shares.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Aug 3, 2023 | PII Polaris Inc. | Director | Sell | 3,225 | $133.28 | $429,828.00 | -18.0% | -34.5% | -40.3% | |
| Jul 27, 2023 | PII Polaris Inc. | Director | Sell | 1,615 | $134.33 | $216,942.95 | -8.3% | -35.3% | -38.4% | |
| Oct 28, 2021 | PII Polaris Inc. | Director | Sell | 10,169 | $115.27 | $1,172,176.02 | -41.5% | -2.9% | -9.7% | |
| Nov 6, 2020 | NAGE Niagen Bioscience, Inc. | Chief Financial Officer | Buy | 5,000 | $4.43 | $22,150.00 | +13.7% | - | - | |
| Mar 15, 2019 | NAGE Niagen Bioscience, Inc. | Chief Financial Officer | Buy | 6,900 | $3.85 | $26,565.00 | +23.2% | - | - | |
| Mar 14, 2019 | NAGE Niagen Bioscience, Inc. | Chief Financial Officer | Buy | 6,725 | $3.99 | $26,832.75 | +29.2% | - | - | |
| Mar 12, 2019 | NAGE Niagen Bioscience, Inc. | Chief Financial Officer | Buy | 7,300 | $3.62 | $26,426.00 | +46.5% | - | - | |
| Mar 11, 2019 | NAGE Niagen Bioscience, Inc. | Chief Financial Officer | Buy | 5,700 | $3.49 | $19,893.00 | +57.0% | - | - | |
| Feb 26, 2019 | PII Polaris Inc. | Director | Buy | 1,125 | $88.59 | $99,660.38 | +7.8% | - | - | |
| Sep 11, 2018 | NAGE Niagen Bioscience, Inc. | Chief Financial Officer | Buy | 5,000 | $3.50 | $17,500.00 | +100.0% | - | - |